Nevolat Injections (liraglutide)

Nevolat doses

Nevolat comes in 5 doses, starting at 0.6mg a day, before gradually building to the maximum 3mg dose over a 5-week period. This gives you a chance to get used to the medication and reduces the chance of side effects.

Your Nevolat dosing schedule will likely be:

• Week 1, 0.6mg per day
• Week 2, 1.2mg per day
• Week 3, 1.8mg per day
• Week 4, 2.4mg per day
• Week 5 onwards, 3mg per day

Each Nevolat pen is filled with 3ml of solution, containing 18mg of liraglutide. This means there isn’t a 0.6mg pen, or a 3mg pen. Instead, you’ll need to select the right dose on your Nevolat pen as you gradually move up each strength.

When injecting, there are a few things to consider. Firstly, you should ensure you avoid injecting in the same place twice, rotating between your tummy, thighs and upper arm. It’s also good to maintain a regular injection schedule, sticking to the same time each day, as it helps make sure the right amount of medication is in your body at any one time.

What happens if I miss a dose?

If you forget to inject Nevolat on time, don’t worry. You’ve got a 12 hour window to take your dose, so make sure you inject straight away if you remember within that time period.

If you miss your injection and it’s been over 12 hours, however, you should skip the day entirely. Don’t worry about doubling up on your dosage the following day, just continue with your routine as normal, injecting your single dose.

If you do happen to forget for 3 days, you should drop down to the lowest dose and work your way back up again. This is because, if you continue at a higher dose after a break, you might experience more side effects.

Nevolat (liraglutide) pricing

A single Nevolat pen can cost around £53.99, with packs of 5 costing anywhere from £95 to £220.

If prescribed on the NHS, Nevolat will cost the standard prescription charge of £9.90 (unless you’re eligible for free prescriptions).

How effective is Nevolat?

Nevolat’s active ingredient, liraglutide, can help patients lose 8% of their starting weight on average. A 2015 study conducted over 56 weeks found that that 2,487 patients on a max dosage lost an average of 8.4kg.

You should also be able to tell whether Nevolat will be effective quite early on. Once you’ve reached the max 3.0mg a day dose and maintained it for 12 weeks, you should have seen a loss of at least 5% of your initial body weight.

If you haven’t lost at least 5% of your body weight, it’s recommended you stop using it. This is because it might not be the most effective weight loss medication for you, and you may find more success with another treatment.

Nevolat vs Wegovy

Nevolat has been shown to be less effective in clinical trials than both Wegovy injections and Wegovy pills.

Nevolat vs Mounjaro

As with Wegovy, Nevolat is typically less effective than Mounjaro at supporting weight loss.

Nevolat vs Saxenda

As both Nevolat and Saxenda contain the same active ingredient, along with a few differing inactive ingredients, they are essentially the same. For this reason, Nevolat tends to be regarded as a ‘generic’, more affordable version of Saxenda.

Is Nevolat the same as Saxenda?

Technically, yes. Inactive ingredients and price points are the only differences that separate Nevolat and Saxenda. The dosage and titration process is the same, and you’ll see very similar results.

Are there any side effects of Nevolat?

As with any prescription treatment, there is the chance of side effects with Nevolat. However, these tend to be mild, and most patients find they go away on their own.

• nausea
• vomiting
• diarrhoea
• headache
• Indigestion and heartburn
• feeling weak or tired
• changed sense of taste
• insomnia
• gallstones
• dizziness
• increased risk of low blood sugar in those with type 2 diabetes

You should not use Nevolat if you have a family history or MTC or MEN 2.

Sources

• Nevolat 6 MG/ML solution for injection in pre-filled pen. (2025) MHRA. [Accessed 16 June 2026]
• Wegovy pen results and data. (2026) Wegovy. [Accessed 16 June 2026]
• Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes. (2022) Jama. [Accessed 16 June 2026]
• A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. (2015) The New England Journal of Medicine. [Accessed 16 June 2026]
• Efficacy and Safety of Liraglutide and Semaglutide on Weight Loss in People with Obesity or Overweight: A Systematic Review. (2022) Dovepress. [Acessed 16 June 2026]
• Liraglutide for managing overweight and obesity. (2020) National Institute for Health and Care Excellence. [Accessed 16 June 2026]
• Early Responders to Oral Semaglutide 25mg: A Post Hoc Analysis of the OASIS 4 Trial. (2026). Novo Nordisk. [Accessed 8th June 2026].
• Oral Semaglutide at a Dose of 25mg in Adults with Overweight or Obesity. (2025). New England Journal of Medicine. [Accessed 16 June 2026].
• Tirzepatide Once Weekly for the Treatment of Obesity. (2022). New England Journal of Medicine. [Accessed 16 June 2026].